Last reviewed · How we verify
Glutamin
At a glance
| Generic name | Glutamin |
|---|---|
| Also known as | L-glutamine |
| Sponsor | Shahid Beheshti University |
| Target | Amino acid transporter |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | FDA-approved |
Approved indications
- Short bowel syndrome
Common side effects
Key clinical trials
- Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation (NA)
- Metabolic Biomarkers in Hashimoto's Thyroiditis and Psoriasis (NA)
- The Safety and Efficacy of TET Enema in the Treatment of UC (NA)
- Trial of Enteral Glutamine on Clinical Outcomes in Critically Ill Patients (PHASE3)
- Trial of Enteral Glutamine on Intestinal Permeability in Critically Ill Patients (PHASE3)
- The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies (PHASE4)
- Randomized, Prospective, Multicenter Study to Compare Enteral Nutrition to Parenteral Nutrition as Feeding Support in Patients Presenting Malignant Hemopathy Who Underwent an Allogeneic Hematopoietic Stem Cell Transplantation. (PHASE3)
- A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Glutamin CI brief — competitive landscape report
- Glutamin updates RSS · CI watch RSS
- Shahid Beheshti University portfolio CI